Episode Details

In this episode of the Trade to Black podcast, Shadd Dales and Anthony Varrell welcome Cresco Labs (OTCQX: CRLBF) CEO Charlie Bachtell to discuss the company’s Q4 and full Fiscal 2024 results. Cresco Labs posted $724 million in annual revenue, reflecting a 6% decline from the previous year, but demonstrated resilience by maintaining adjusted gross profit levels consistent with 2023. Adjusted EBITDA improved 15% year-over-year, reaching $200 million, while operating cash flow rose $74 million to $132 million. Capital expenditures were managed at $20 million, and the company reduced its debt by retiring $40 million of its 2026 note in Q4.Despite these achievements, Cresco faced challenges, including price compression in key markets like Illinois and Pennsylvania, which impacted wholesale revenue and margins. We learn what the 3 main takeaways from Cresco Labs' earnings, as well what cannabis investors should avoid focusing on in the cannabis industry in 2025. Plus, Viridian Capital Advisors CFA, Frank Colombo joins us again to recap the latest cannabis earnings season. He’ll highlight standout performers, address ongoing concerns in the sector, and share his perspective on what investors should focus on moving forward.#stockmarket #cannabisstocks #cannabisearnings #stocks #earnings #topcannabisstocks #potstocks #weedstocks #cannabis #marijuana #cannabistrends #cannabisnewsWant to see last week's recap?   • TDR’s Biggest Developments for the We...  Want to see more Cannabis Reform videos?   • Cannabis Legalization: Why Your Opini...     • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thed